Advisor Group
CELGZ

Advisor Group’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Advisor Group’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1
Closed – – 5648
2019
Q3 		$0 Hold
1
– – ﹤0.01% 5605
2019
Q2 		$0 Hold
1
– – ﹤0.01% 5550
2019
Q1 		$0 Hold
1
– – ﹤0.01% 5505
2018
Q4 		$0 Hold
1
– – ﹤0.01% 5445
2018
Q3 		$0 Hold
1
– – ﹤0.01% 5399
2018
Q2 		$0 Hold
1
– – ﹤0.01% 5219
2018
Q1 		$0 Hold
1
– – ﹤0.01% 5237
2017
Q4 		$0 Hold
1
– – ﹤0.01% 5237
2017
Q3 		$0 Hold
1
– – ﹤0.01% 5126
2017
Q2 		$0 Hold
1
– – ﹤0.01% 5082
2017
Q1 		$0 Hold
1
– – ﹤0.01% 4965
2016
Q4 		$0 Buy
+1
New +$1 ﹤0.01% 4822

Advisor Group's CELGZ Position: Q4 2019 in Review

Advisor Group sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 1 share.

Advisor Group first reported a position in CELGZ in Q4 2016 and held it in 12 quarters. The position peaked at $0 in Q3 2019. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.

  • Advisor Group reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • Advisor Group sold 1 Celgene Corporation Contingent Value Rights share in Q4 2019.
  • Advisor Group first reported a position in Celgene Corporation Contingent Value Rights in Q4 2016 and held it in 12 quarters.
  • Advisor Group's Celgene Corporation Contingent Value Rights position peaked at $0 in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.